Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 190 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named S 932. Clear
Clear
Q1
THE KPM GROUP DC LLC for PRAXIS PRECISION MEDICINES
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $40,000.00 income
Pharmacy
View →
Q1
THE KPM GROUP DC LLC for ASTRIA THERAPEUTICS, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $40,000.00 income
Pharmacy
View →
Q1
PTC THERAPEUTICS, INC. for PTC THERAPEUTICS, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · House · Senate
Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q1
AKIN GUMP STRAUSS HAUER & FELD for BIOTECHNOLOGY INNOVATION ORGANIZATION
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Health Issues
View →
Q1
EVERYLIFE FOUNDATION FOR RARE DISEASES for EVERYLIFE FOUNDATION FOR RARE DISEASES
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Health Issues
View →
Q1
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. for AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Health Issues, Taxation/Internal Revenue Code, Tobacco, Budget/Appropriations
View →
Q1
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) for BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues
View →
Q1
TIBER CREEK GROUP for ACADIA PHARMACEUTICALS, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $80,000.00 income
Health Issues, Taxation/Internal Revenue Code
View →
Q1
LMH STRATEGIC SOLUTIONS for STEALTH BIOTHERAPEUTICS INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $10,000.00 income
Health Issues
View →
Q1
BRIDGEBIO PHARMA, INC. for BRIDGEBIO PHARMA, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate
Pharmacy
View →
Q1
ASSOCIATION FOR CLINICAL ONCOLOGY for ASSOCIATION FOR CLINICAL ONCOLOGY
1st Quarter (Jan 1 - Mar 31) 2025 · Virginia · House · Senate
Medicare/Medicaid, Health Issues, Tobacco, Budget/Appropriations
View →
Q1
MEHLMAN CONSULTING, INC. for ULTRAGENYX PHARMACEUTICAL, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $60,000.00 income
Health Issues
View →
Q1
IONIS PHARMACEUTICALS, INC. for IONIS PHARMACEUTICALS, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q1
CURE SMA for CURE SMA
1st Quarter (Jan 1 - Mar 31) 2025 · Illinois · House · Senate
Health Issues, Budget/Appropriations, Civil Rights/Civil Liberties, Aviation/Airlines/Airports
View →
Q1
HEALTHCARE INSTITUTE OF NEW JERSEY for HEALTHCARE INSTITUTE OF NEW JERSEY
1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · House · Senate
Health Issues
View →
Previous Page 8 of 8

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem